HIV Infections
3,875
117
182
3,113
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
642 trials with published results (17%)
Research Maturity
3113 completed trials (80% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.3%
168 terminated out of 3875 trials
94.9%
+8.3% vs benchmark
20%
764 trials in Phase 3/4
21%
642 of 3113 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3113 completed trials
Clinical Trials (3875)
Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)
Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants
Metabolic Liver Disease in Newly Diagnosed People Living With HIV (MASHIV-TR)
Infectious Disease (ID) Testing OUtreach in Carceral Hubs
A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1
A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV)
Impact of HIV-1 and Aging on Mucosal Vaccine Responses
Screen2Prevent (S2P)
A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab
The Ganchero Intervention for Migrant People Who Inject Drugs From Puerto Rico in New York City
Safety and Immunogenicity of Clade C ALVAC and gp120 HIV Vaccine
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
Safety and Virologic Effect of a Human Monoclonal Antibody (VRC01) Administered Intravenously to Adults During Early Acute HIV Infection
Evaluation of Conditional Cash Transfers to Increase Retention in PMTCT Services in Akwa Ibom State, Nigeria
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART)
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
Pharmacokinetic Study of Long-acting Antiretrovirals and Contraceptives in HIV
SmartSteps: A Context-Aware, PrEP Adherence Intervention for Individuals With Substance Use Disorder
Developing an HIV Disclosure Intervention for Men in Uganda